1
results found
Background Rituximab based chemotherapy regimens, particularly R-CHOP, are highly effective for the treatment of B-cell lymphoma (BCL) but are frequently complicated by pulmonary adverse effects (PAEs...
rituximab
pulmonary adverse effects
thymosin α1
intravenous immunoglobulin
event-free survival
SinoXiv